Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group

Clicks: 541
ID: 119238
2014
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #1 of 5 articles by views in pediatric blood & cancer

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
These findings suggest that the therapeutic strategy for children with EBV-HLH could be tailored according to the laboratory findings at diagnosis.
Reference Key
k2014pediatricprognostic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kogawa K;Sato H;Asano T;Ohga S;Kudo K;Morimoto A;Ohta S;Wakiguchi H;Kanegane H;Oda M;Ishii E;;
Journal pediatric blood & cancer
Year 2014
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/24535916
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Child Infant Remission Induction preschool Clinical Trial Multicenter Study Retrospective Studies herpesvirus 4 survival rate lymphohistiocytosis hemophagocytic* / diagnosis disease-free survival etoposide / administration & dosage antineoplastic agents human* japan / epidemiology age of onset asian continental ancestry group cyclosporine / administration & dosage data collection* immunosuppressive agents / administration & dosage adrenal cortex hormones / administration & dosage pmid:24535916 doi:10.1002/pbc.24980 kazuhiro kogawa hiroki sato eiichi ishii phytogenic / administration & dosage bilirubin / blood epstein-barr virus infections* / blood epstein-barr virus infections* / diagnosis epstein-barr virus infections* / drug therapy epstein-barr virus infections* / mortality hyperbilirubinemia / blood hyperbilirubinemia / diagnosis hyperbilirubinemia / drug therapy hyperbilirubinemia / mortality hemophagocytic* / blood hemophagocytic* / drug therapy hemophagocytic* / mortality

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.